These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 26137805)

  • 1. Valsartan-induced cardioprotection involves angiotensin II type 2 receptor upregulation in isolated ischaemia and reperfused rat hearts.
    Li KY; Zhang YJ
    Acta Cardiol; 2015 Feb; 70(1):67-72. PubMed ID: 26137805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mechanism of cardioprotection against ischemia/reperfusion injury by valsartan: an experiment with isolated rat hearts].
    Zhang YJ; Bai XJ; Qi ZM; Wang HX
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(47):3350-3. PubMed ID: 16409843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of angiotensin II type 2 receptor and limitation of myocardial stunning by angiotensin II type 1 receptor blockers during reperfused myocardial infarction in the rat.
    Jugdutt BI; Menon V
    J Cardiovasc Pharmacol Ther; 2003 Sep; 8(3):217-26. PubMed ID: 14506547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cumulative effects of AT1 and AT2 receptor blockade on ischaemia-reperfusion recovery in rat hearts.
    Ryckwaert F; Colson P; Guillon G; Foëx P
    Pharmacol Res; 2005 Jun; 51(6):497-502. PubMed ID: 15829428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AT1 receptor blockade limits myocardial injury and upregulates AT2 receptors during reperfused myocardial infarction.
    Jugdutt BI; Menon V
    Mol Cell Biochem; 2004 May; 260(1-2):111-8. PubMed ID: 15228092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valsartan-induced cardioprotection involves angiotensin II type 2 receptor upregulation in dog and rat models of in vivo reperfused myocardial infarction.
    Jugdutt BI; Menon V
    J Card Fail; 2004 Feb; 10(1):74-82. PubMed ID: 14966778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aliskiren reduces myocardial ischemia-reperfusion injury by a bradykinin B2 receptor- and angiotensin AT2 receptor-mediated mechanism.
    Koid SS; Ziogas J; Campbell DJ
    Hypertension; 2014 Apr; 63(4):768-73. PubMed ID: 24420538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [On angiotensin II receptor distribution after myocardial infarction in dogs].
    Qu XF; Li JJ; Xi Y; Shen JX; Xiu CH; Yue L; Wang GZ; Huang YL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Apr; 37(4):358-62. PubMed ID: 19791474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of angiotensin II type 2 receptor blockade on activation of mitogen-activated protein kinases after ischemia-reperfusion in isolated working rat hearts.
    Kumar D; Menon V; Ford WR; Clanachan AS; Jugdutt BI
    J Cardiovasc Pharmacol Ther; 2003 Dec; 8(4):285-96. PubMed ID: 14740078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin subtype-2 receptors inhibit renin biosynthesis and angiotensin II formation.
    Siragy HM; Xue C; Abadir P; Carey RM
    Hypertension; 2005 Jan; 45(1):133-7. PubMed ID: 15534073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AT2 receptor and apoptosis during AT1 receptor blockade in reperfused myocardial infarction in the rat.
    Jugdutt BI; Menon V
    Mol Cell Biochem; 2004 Jul; 262(1-2):203-14. PubMed ID: 15532725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radionuclide imaging of angiotensin II type 1 receptor upregulation after myocardial ischemia-reperfusion injury.
    Higuchi T; Fukushima K; Xia J; Mathews WB; Lautamäki R; Bravo PE; Javadi MS; Dannals RF; Szabo Z; Bengel FM
    J Nucl Med; 2010 Dec; 51(12):1956-61. PubMed ID: 21078800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valsartan ameliorates ageing-induced aorta degeneration via angiotensin II type 1 receptor-mediated ERK activity.
    Shan H; Zhang S; Li X; Yu K; Zhao X; Chen X; Jin B; Bai X
    J Cell Mol Med; 2014 Jun; 18(6):1071-80. PubMed ID: 24548645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the insurmountable angiotensin AT1 receptor antagonist candesartan and the surmountable antagonist losartan on ischemia/reperfusion injury in rat hearts.
    Wang QD; Sjöquist PO
    Eur J Pharmacol; 1999 Sep; 380(1):13-21. PubMed ID: 10513555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor beta receptor endoglin is expressed in cardiac fibroblasts and modulates profibrogenic actions of angiotensin II.
    Chen K; Mehta JL; Li D; Joseph L; Joseph J
    Circ Res; 2004 Dec; 95(12):1167-73. PubMed ID: 15539634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AT1 and aldosterone receptors blockade prevents the chronic effect of nandrolone on the exercise-induced cardioprotection in perfused rat heart subjected to ischemia and reperfusion.
    Marques-Neto SR; Ferraz EB; Rodrigues DC; Njaine B; Rondinelli E; Campos de Carvalho AC; Nascimento JH
    Cardiovasc Drugs Ther; 2014 Apr; 28(2):125-35. PubMed ID: 24258356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical role of AT1 receptor expression after ischemia/reperfusion in isolated rat hearts: beneficial effect of antisense oligodeoxynucleotides directed at AT1 receptor mRNA.
    Yang BC; Phillips MI; Zhang YC; Kimura B; Shen LP; Mehta P; Mehta JL
    Circ Res; 1998 Sep; 83(5):552-9. PubMed ID: 9734478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AT1 receptor blockade alters metabolic, functional and structural proteins after reperfused myocardial infarction: detection using proteomics.
    Jugdutt BI; Sawicki G
    Mol Cell Biochem; 2004 Aug; 263(1-2):179-88. PubMed ID: 15524179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valsartan and telmisartan abrogate angiotensin II-induced downregulation of ABCA1 expression via AT1 receptor, rather than AT2 receptor or PPARγ activation.
    Chen HY; Xu Z; Chen LF; Wang W; Fang Q; Yan XW
    J Cardiovasc Pharmacol; 2012 Jun; 59(6):570-5. PubMed ID: 22392065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological profile of valsartan, a non-peptide angiotensin II type 1 receptor antagonist. 4th communication: improvement of heart failure of rats with myocardial infarction by valasartan.
    Hayashi N; Fujimura Y; Yamamoto S; Kometani M; Nakao K
    Arzneimittelforschung; 1997 May; 47(5):625-9. PubMed ID: 9205776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.